Dr. Sreenath Thati Ganganna, a pediatric neurologist and epileptologist at the University of Iowa Stead Family Children's Hospital, has been named a 2026 Castle Connolly Top Doctor, marking the third consecutive year he has received this designation. The Castle Connolly Top Doctors list, published at castleconnolly.com, selects only 7 percent of the nation's licensed physicians annually based on peer nominations and rigorous review of medical education, training, and hospital appointments.
As Clinical Associate Professor and Clinical Director of the Division of Neurology, Dr. Thati Ganganna provides specialized care for pediatric neurology patients, with clinical interests focusing on drug-resistant epilepsy management. His expertise encompasses presurgical evaluation, neurostimulation therapies including Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS), along with ketogenic dietary therapies. This recognition underscores the advanced capabilities available at the University of Iowa Stead Family Children's Hospital, which is itself recognized as a Castle Connolly Top Hospital.
The hospital's comprehensive facilities include an on-site pediatric epilepsy monitoring unit, EEG laboratory, and advanced neuroimaging suites, enabling seamless coordination between diagnostic testing and clinical consultation. These resources, combined with close collaboration with a specialized pediatric neurosurgery team, create an ecosystem for cutting-edge neurological care. For business and technology leaders, this highlights how institutional infrastructure and specialized expertise converge to drive medical innovation, particularly in complex pediatric conditions.
Dr. Thati Ganganna's extensive training includes pediatric residencies at the University College of Medical Sciences in Delhi, India and Brookdale Hospital and Medical Center in Brooklyn, New York, followed by a child neurology fellowship at Rainbow Babies & Children's Hospital. He completed two additional fellowships at the University of Michigan Health System in epilepsy and clinical neurophysiology with EEG focus. He holds board certifications in Neurology with Special Qualification in Child Neurology and the Epilepsy subspecialty from the American Board of Psychiatry and Neurology.
Beyond clinical practice, Dr. Thati Ganganna serves as Director of the Epilepsy Fellowship program, training future specialists, and contributes academically as an Associate Editor for the Epilepsy section of the Journal of Child Neurology. His publications appear in journals including Stroke, Epilepsy & Behavior Case Reports, Clinical Pediatrics, and the European Journal of Paediatric Neurology. This multifaceted role demonstrates how clinical excellence, research, and education intersect to advance medical fields.
The repeated recognition of specialists like Dr. Thati Ganganna signals evolving standards in pediatric neurology care, particularly for drug-resistant epilepsy where neurostimulation technologies represent a growing intersection of medicine and technology. For industry observers, such designations validate institutions that successfully integrate clinical expertise, advanced facilities, and training programs. The Castle Connolly selection process, where doctors cannot pay to be selected, adds credibility to these distinctions, offering benchmarks for healthcare quality assessment.
